Listeria monocytogenes-associated endovascular infections: A study of 71 consecutive cases

Affiliation auteurs!!!! Error affiliation !!!!
TitreListeria monocytogenes-associated endovascular infections: A study of 71 consecutive cases
Type de publicationJournal Article
Year of Publication2019
AuteursShoai-Tehrani M, Pilmis B, Maury MM, Robineau O, Disson O, Jouvion G, Coulpier G, Thouvenot P, Bracq-Dieye H, Vales G et al.
JournalJOURNAL OF INFECTION
Volume79
Pagination322-331
Date PublishedOCT
Type of ArticleArticle
ISSN0163-4453
Mots-clésaneurysm, Endocarditis, Listeria monocytogenes, Listeriosis, Prosthesis
Résumé

Background: Listeria monocytogenes-associated endovascular infections are not well characterized. Methods: Retrospective study of 71 culture-proven cases reported to the French National Reference Center for Listeria from 1993 to 2018. Results: Seventy-one cases were identified: 42 with vascular aneurysms/prosthetic infections, 27 with endocarditis, 2 with both. Fifty-eight were men (82%); median age was 75 years [46-92]; 93% reported co-morbidities (66/71), including 50% with immunosuppressive conditions. Vascular infections consisted of infected aneurysms (68%) or prosthetic graft infections (32%); vascular rupture was reported in 25/42 (60%). Tissue samples grew L. monocytogenes in 98% (43/44) and blood cultures in 64% (27/42). Endocarditis cases involved prosthetic or native valves or intracardiac devices in respectively 62% (18/29), 28% (8/29) and 10% (3/29). Infected valves were aortic (62%, 16/26), mitral (31%, 8/26) or both (8%, 2/26); 38% patients required surgery; 45% displayed heart failure; 17% had concomitant neurolisteriosis. In-hospital mortality in vascular infections was 12% (5/42) and 41% (12/29) for Lm-associated endocarditis. Conclusions: Endovascular listeriosis is a rare but severe infection. It manifests as vascular infections and endocarditis, mostly in older patients with vascular or cardiac valve prosthetic devices and co-morbidities. Mortality in Lm-associated endocarditis is twice higher than with other pathogens, requiring prompt recognition and treatment. (C) 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

DOI10.1016/j.jinf.2019.07.013